France: Ceva unlocks access to gene therapy pipeline with Scout Bio acquisition
Animal health company, Ceva Santé Animale (Ceva), acquired US-based Scout Bio, a biotech company focused on pet therapies. The move represents a significant leap...
Switzerland: Bruker accelerates entry into lab automation with Chemspeed acquisition
Nasdaq listed Bruker Corporation, a manufacturer of scientific instruments for molecular and materials research, is acquiring Chemspeed Technologies, a Swiss provider of vendor-agnostic automated...
UK: Kyowa Kirin completes acquisition of Orchard Therapeutics
Kyowa Kirin, a Japan-based global specialty pharmaceutical company, has completed the acquisition of all outstanding shares in UK-based Orchard Therapeutics, a gene therapy developer.
The...
UK: Aura Fertility acquired by IBSA Pharma UK
IBSA Pharma UK, the UK affiliate of the Swiss multinational pharmaceutical company and a major player in the field of reproductive medicine, has acquired...
Germany: Stille completes €36m acquisition of Fehling
Stille, a Sweden-based developer and manufacturer of medical devices, has completed the acquisition of the German instrument provider Fehling for €36m (US$39m) in cash.
Through...
India: Medi Assist lists in India following pre-IPO investment from Novo Holdings
Medi Assist, the largest third-party health benefits administrator in India by revenue and premiums under management, has completed its IPO on the Bombay Stock...
US: Sanofi to acquire Inhibrx for up to US$2.2bn
France headquartered global healthcare company Sanofi is acquiring Inhibrx, a publicly traded clinical-stage biopharmaceutical company focused on developing a broad pipeline of novel biologic...
The Netherlands: Acquisition of ZoBio provides foundation for Oncodesign’s European ambitions
France-based CRO, Oncodesign Services (ODS), has expanded its international presence with the acquisition of ZoBio, a Dutch CRO expert in biophysics-based small molecule drug...
UK: Eliquent Life Sciences expands geographic reach with acquisition of RApport
Eliquent Life Sciences, a global regulatory consulting firm for the life sciences industry, has acquired RApport Global Strategic Services. RApport is a UK based...
Sweden: Camurus carries out directed share issue to raise SEK1.09bn
Swedish biopharmaceutical company, Camurus, carried out a directed share issue of 2 million share on January 18, at a subscription price of SEK545 per...
Advertisement
